Could a second dose of steroids help premature babies breathe easier?

NCT ID NCT02939742

First seen Jun 30, 2026 · Last updated Jul 01, 2026 · Updated 1 time

Summary

This study investigates whether giving a repeat course of betamethasone, a steroid, to pregnant women with preterm premature rupture of membranes (PPROM) can improve health outcomes for their premature babies. The main goal is to see if it shortens the baby's stay in the neonatal intensive care unit (NICU) and reduces overall complications like respiratory distress. The trial compares a second course of betamethasone against a placebo in women who have already received one standard course.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Betamethasone (a corticosteroid)

What this could lead to

If effective, a repeat course of betamethasone could reduce the time premature babies spend in the NICU and lower their risk of breathing problems and other complications.

What could go wrong

This is a small, early-phase study, so results may not be conclusive. Corticosteroids carry risks for both mother and baby, and the benefits of a repeat course are not yet proven.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PPROM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

adult acute respiratory distress syndrome preterm premature rupture of the membranes respiratory distress syndrome in premature infants

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University of Texas Medical Branch in Galveston

    Galveston, Texas, 77555, United States